ICON Central Laboratories Launches New Facility In Singapore To Meet Spiking Demand
This article was originally published in PharmAsia News
Executive SummarySHANGHAI - ICON Central Laboratories recently moved its operation in Singapore to a larger facility to keep pace with a sharp rise in demand for its lab services across Asia
You may also be interested in...
Acquisition of BeijingWits will boost ICON’s clinical trial capabilities in China and the Asia Pacific region.